PDK4 and ovarian carcinoma: For instance, 12-O-deacetyl-phomoxanthone A (12-ODPXA), a xanthone compound, inhibits ovarian cancer growth and metastasis by targeting pyruvate dehydrogenase kinase 4 (PDK4) 68.